Disease-Vaccine-Landing-Page/Meningitis/history

In 1985, when the CDC’s Advisory Committee on Immunization Practices (ACIP) made its first recommendations on the recently licensed tetravalent meningococcal polysaccharide vaccine targeting serogroups A, C, Y, and W-135...

In 1952, public health officials reported infants to be four times more likely than school children and adults to develop meningococcal disease and that the disease was more likely to...

Between 1918 and 1928, horse antiserum was primarily used to treat meningococcal meningitis and public health officials reported that the antiserum was relatively successful in decreasing mortality rates from the...